Home » Topics » Regulatory

Regulatory
RSS

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

First localized treatment for fatal brain cancer approved by the FDA

Sep. 27, 1996

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

Topical clotrimazole for the treatment of actinic keratosis

Sep. 27, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

New use for 5-HT2 antagonist

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

Use of bisaramil in oxidative stress-related conditions

Sep. 20, 1996

Valaciclovir for restenosis

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.